China Isotope & Radiation Corp. (1763) Stock Statistics & Valuation Metrics

China Isotope & Radiation Corp. has a market cap or net worth of HK$3.76B. The enterprise value is HK$9.93B.

China Isotope & Radiation Corp. has 79,968,800 shares outstanding. The number of shares has decreased by -2.65% in one year.

China Isotope & Radiation Corp.’s return on equity (ROE) is 0.06 and return on invested capital (ROIC) is 5.34%.

The current PE Ratio of China Isotope & Radiation Corp. is 10.4. China Isotope & Radiation Corp.’s PEG ratio is -0.85.

In the last 12 months, China Isotope & Radiation Corp. had revenue of 7.00B and earned 318.95M in profits. Earnings per share was 1.00.

In the last 12 months, operating cash flow was 826.76M and capital expenditures -584.34M, giving a free cash flow of 242.42M billion.

China Isotope & Radiation Corp. pays an annual dividend of HK$0.116, resulting in a dividend yield of 4.2%

China Isotope & Radiation Corp. upcoming earnings date is Mar 31, 2027, TBA (Confirmed).

China Isotope & Radiation Corp. as a current ratio of 1.76, with Debt / Equity ratio of 53.94%

In the past 12 months, China Isotope & Radiation Corp. has paid 330.79M in taxes.

China Isotope & Radiation Corp. EV to EBITDA ratio is 5.03, with an EV/FCF ratio of -122.67.

China Isotope & Radiation Corp. has HK$2.55B in cash and marketable securities with HK$2.86B in debt, giving a net cash position of -HK$310.03M billion.

Gross margin is 49.52%, with operating margin of 13.09%, and net profit margin of 4.56%.

The average price target for China Isotope & Radiation Corp. is ―, which is 11.43% higher than the current price. The consensus rating is ―